Clinical trial
Stem Cell Therapy as Adjunct to Revascularization
NCT00463853 · US Department of Veterans Affairs, U.S. Fed · Withdrawn
Key facts
| NCT number | NCT00463853 |
|---|---|
| Title | Stem Cell Therapy as Adjunct to Revascularization |
| Official title | Stem Cell Therapy as Adjunct to Revascularization: STAR |
| Acronym | STAR |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | University of Utah |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Coronary Arteriosclerosis, Coronary Artery Bypass Graft, Myocardial Revascularization |
| Intervention type | Procedure, Radiation |
| Interventions | Autologous stem cell therapy, CABG, CMRI |
| Enrollment | 0 |
| Start date | Aug 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Apr 20, 2007 |
| Last update posted | Jun 11, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: